PFE vs BMY
Pfizer Inc. vs Bristol Myers Squibb — AI-powered side-by-side comparison
| Metric | PFE | BMY |
|---|---|---|
| AI Score | 68 | 70 |
| Price | $24.19 | $57.56 |
| P/E Ratio | 18.44× | 19.93× |
| ROE | 8.4% | 41.6% |
| Revenue Growth YoY | 1.4% | 1.8% |
| Gross Margin | 74.8% | 53.7% |
| Debt / Equity | 0.75× | 2.44× |
| Dividend Yield | 7.1% | 4.3% |
| RSI (14) | 44.8 | 53.8 |
| Beta | 0.2851 | 0.235 |
| Expected Upside | +7.7% | +4.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
PFE Full Analysis
BMY Full Analysis